NovoCure (NVCR)

NovoCure (NVCR) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• NVCR last traded at $13.23, 0.61% on the day.
• NovoCure: market cap $1.54B, P/E -12.5, revenue $725.39M over the last four quarters.
• Over the past year NVCR returned 3.20%; year to date 2.32%.

Updated 2026-11-02 20:38 UTC